Molecular Pathways in Suppression and Development of T Lineage Lymphomas
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
批准号:
7313293
负责人:
CRAIG H BASSING
金额:
$31.35万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-05-31
关键词:
Animal ModelAntigen ReceptorsCell Cycle ProgressionCell LineCellsChromatinChromosome DeletionChromosome PaintingConditionDNADNA Double Strand BreakDNA biosynthesisDNA strand breakDefectDevelopmentDiagnosticDouble Strand Break RepairEnsureExhibitsFluorescent in Situ HybridizationFrequenciesG1 ArrestG1 PhaseGenesGenome StabilityGenomic InstabilityGenomicsGenotypeH2AFX geneHistonesHumanKnowledgeLeadLesionLocationLoss of HeterozygosityLymphomaMaintenanceMalignant - descriptorMalignant NeoplasmsMapsMolecularMonitorMusNonhomologous DNA End JoiningNumbersOncogenesOncogenicPathway interactionsPhosphotransferasesPolymerase Chain ReactionPredispositionPreventionProliferatingRepair ComplexReporterRoleSolid NeoplasmSouthern BlottingStressSystemT-Cell DevelopmentT-Cell ReceptorTP53 geneTestingTherapeuticThymic LymphomaV(D)J RecombinationVariantataxia telangiectasia mutated proteindosagehomologous recombinationhuman H2AX proteinhuman diseasein vivomanmetaplastic cell transformationnovelpreventrecombinational repairrepairedresponsethymocytetooltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chromosomal DMA double strand breaks (DSBs) are induced by a variety of factors and occur constantly in every cell. The proper repair of DSBs is essential for maintaining genomic stability and preventing cellular transformation. We recently demonstrated that the Ataxia Telangiectasia Mutated (ATM) protein, which is the master regulator of the cellular DSB response, is required during chromosomal DSB repair to maintain broken DNA ends in repair complexes. An immediate substrate of ATM is H2AX, a core histone variant that is phosphorylated in chromatin around DSBs. We have demonstrated that expression of both allelic copies of H2ax is essential for error-free DSB repair, maintanence of genomic stability, and suppression of cancer. Notably, deletion or loss of heterozygosity (LOH) of the H2AX gene appears commonly in a wide variety of human tumors, suggesting similar dosage-dependent H2AX functions in man. In this application, we propose to elucidate mechanisms by which H2AX functions downstream of ATM and related kinases to promote error-free DSB repair, maintain genomic stability, and suppress malignant transformation. The specific hypothesis to be investigated is that one critical function of H2AX is to hold broken DNA strands together and ensure that DNA ends are properly repaired. In Specific Aim 1, we will test our hypothesis that H2AX functions during V(D)J recombination to hold together broken DNA strands upon G1 to S transition and, thereby, prevent antigen receptor locus translocations. We will employ novel cell lines and primary thymocytes to induce DSB intermediates at specific genomic locations in G1 phase cells and monitor their repair during continued cell cycle progression. In Specific Aim 2, we will test our hypothesis that ATM independent H2AX functions downstream of other kinases are essential for normal DSB repair, prevention of genomic instability, and suppression of cancer. We will utilize cell lines and thymocyes deficient for H2AX and ATM to elucidate the roles of ATM independent H2AX functions. In Specific Aim 3, we will test our hypothesis that H2AX functions at replication-associated DSBs induced during normal and oncogene-driven proliferation to prevent p53 deletions that drive malignant transformation. We will directly evaluate the ability of H2AX to suppress tumors with p53 deletions. Relevance: Our studies will lead to a greater understanding of the molecular mechanisms through which genomic integrity is maintained and how defects in these can lead to malignant transformation. This knowledge and the animal models generated will contribute to the development of more effective diagnostic and/or therapeutic tools for human cancers. Consequently, our proposed studies will have broad implications for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:10538891
-
项目类别:
-
资助金额:$51.72万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Exploring a Functional Role of Chromosome Loop Extrusion Direction on Regulating Genome Biology
-
批准号:10606672
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:10664014
-
项目类别:
-
资助金额:$55.7万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10684807
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10231184
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10466824
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10020899
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:9917182
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:10238038
-
项目类别:
-
资助金额:$73.1万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:9753111
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:9447778
-
项目类别:
-
资助金额:$81.79万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:8885002
-
项目类别:
-
资助金额:$24.5万
-
财政年份:2015
-
负责人:CRAIG H BASSING
-
依托单位:
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:8891814
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8230660
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:7725686
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8444678
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8029532
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:7624244
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:7841774
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:7455902
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
海外基金